Natalie Walker1, Chris Bullen, Hayden McRobbie. 1. Clinical Trials Research Unit, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1072, New Zealand. n.walker@ctru.auckland.ac.nz
Abstract
INTRODUCTION: Current smoking cessation treatments largely address pharmacological dependence on nicotine. New approaches are needed that address both nicotine dependence and psychological dependence on cigarettes as the source of nicotine. One such approach is the use of cigarettes with reduced nicotine content. METHODS: We reviewed the available literature on the use of reduced-nicotine content cigarettes as a cessation aid. RESULTS: One case series study and trial data indicate that reduction in the level of nicotine in cigarette tobacco can reduce the level of nicotine dependence in smokers and do so without adverse effects on cardiovascular biomarkers or significant compensatory smoking. We identified three clinical trials (total n = 489) that suggest that smokers can dissociate nicotine delivery from the act of smoking if they use reduced-nicotine content cigarettes in combination with nicotine replacement therapy. DISCUSSION: The identified studies point to a benefit but involved only a small number of participants and provide only limited data on long-term abstinence. More definitive evidence from larger trials with longer follow-up is needed to clarify the role of reduced nicotine cigarettes as an aid to smoking cessation.
INTRODUCTION: Current smoking cessation treatments largely address pharmacological dependence on nicotine. New approaches are needed that address both nicotine dependence and psychological dependence on cigarettes as the source of nicotine. One such approach is the use of cigarettes with reduced nicotine content. METHODS: We reviewed the available literature on the use of reduced-nicotine content cigarettes as a cessation aid. RESULTS: One case series study and trial data indicate that reduction in the level of nicotine in cigarette tobacco can reduce the level of nicotine dependence in smokers and do so without adverse effects on cardiovascular biomarkers or significant compensatory smoking. We identified three clinical trials (total n = 489) that suggest that smokers can dissociate nicotine delivery from the act of smoking if they use reduced-nicotine content cigarettes in combination with nicotine replacement therapy. DISCUSSION: The identified studies point to a benefit but involved only a small number of participants and provide only limited data on long-term abstinence. More definitive evidence from larger trials with longer follow-up is needed to clarify the role of reduced nicotine cigarettes as an aid to smoking cessation.
Authors: David A Macqueen; Bryan W Heckman; Melissa D Blank; Kate Janse Van Rensburg; David E Evans; David J Drobes Journal: Psychopharmacology (Berl) Date: 2012-03-20 Impact factor: 4.530
Authors: Yan S Ding; Patricia Richter; Bryan Hearn; Liqin Zhang; Roberto Bravo; Xizheng Yan; Jose J Perez; Michele Chan; Jared Hughes; Patrick Chen; Wayne Chen; Joshua Wong; Sydney Holmberg; Shakia Smith; Morgan Larango; Liza Valentín-Blasini; Clifford H Watson Journal: Tob Regul Sci Date: 2017-01-01
Authors: Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-11-10 Impact factor: 4.254
Authors: Neal L Benowitz; Katherine M Dains; Sharon M Hall; Susan Stewart; Margaret Wilson; Delia Dempsey; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-02-21 Impact factor: 4.254
Authors: Pasquale Caponnetto; Roberta Auditore; Cristina Russo; Giorgio Carlo Cappello; Riccardo Polosa Journal: Int J Environ Res Public Health Date: 2013-01-28 Impact factor: 3.390
Authors: Natalie K Walker; Colin Howe; Chris Bullen; Michele Grigg; Marewa Glover; Hayden McRobbie; Murray Laugesen; Stephen Vander Hoorn; Robyn Whittaker Journal: BMC Public Health Date: 2011-01-14 Impact factor: 3.295
Authors: Riccardo Polosa; Pasquale Caponnetto; Fabio Cibella; Jacques Le-Houezec Journal: Int J Environ Res Public Health Date: 2015-03-24 Impact factor: 3.390
Authors: Muhammad Aziz Rahman; Nicholas Hann; Andrew Wilson; George Mnatzaganian; Linda Worrall-Carter Journal: PLoS One Date: 2015-03-30 Impact factor: 3.240